Sign in for the best experience.
Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis
A retrospective cohort study did not observe a significant association between therapy-associated adverse events in an azithromycin- vs clarithromycin-based regimen or a rifampin- vs rifabutin-based regimen.
RELATED VISUAL ABSTRACT »
National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029
A cross-sectional, retrospective study highlights the complexity of care required by patients with COPD, their unmet needs, and the gaps in care.
VISIT THE EQUITY TOPIC COLLECTION »
Epidemiology of Intensive Care Patients Classified as a Third Sex in Australia and New Zealand
A retrospective, observational study of 525 patients who self-classified as third sex finds that this population had a different diagnostic case mix but similar outcomes to the groups classified as female or male.
Need a visual? Here's a summary of the key findings from this article »
Variable Practice, Variable Results: Impact of Postinterview Communication Practices Among Critical Care Medicine/Pulmonary and Critical Care Medicine Fellowship Applicants and Program Directors
Original research shows that both applicants and program directors desire clearer guidance on postinterview communication practices to minimize ambiguous and misleading communication.
RELATED PODCAST »
Performance of Claims-Based Algorithms for Adherence to Positive Airway Pressure Therapy in Commercially Insured Patients With OSA
A study of 213,341 patients shows that those with consistent CPAP use were frequently identified by claims-based algorithms as nonadherent, whereas many with inconsistent CPAP use were classified by claims-based algorithms as adherent.
Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy
Original thoracic oncology research shows no impact of lung metastasis-directed therapy modality on overall survival.
SHOW MORE ARTICLES
Effect of Atypical-Sleep EEG Patterns on Weaning From Prolonged Mechanical Ventilation
Prophylactic Minocycline for Delirium in Critically Ill Patients
A Prayer for My Children
Recurrence-Free Survival in Patients With Surgically Resected Non-Small Cell Lung Cancer
Discussing and Teaching About Race and Health Inequities
Each month, the journal CHEST® features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine. It also houses our highly regarded clinical practice guidelines and consensus statements.
In addition, readers can find the latest research posted in the Online First section each week and access series that provide insight into relevant clinical areas and address controversial issues, fostering discussion among physicians.
READ THE CURRENT ISSUE
All CHEST members receive a free online subscription to the journal CHEST. Not yet a member? See what CHEST has to offer »
CME for CHEST Journal CHEST now offers CME credit for journal readers! Several articles are eligible each month; look for the symbol throughout the CHEST website. To claim, log in to your CHEST account (or quickly create a free one if you're new to CHEST), find the article you’ve read, and complete the posttest.
CHEST® Critical Care, a new open access journal, will advance the care of patients served by multidisciplinary clinicians across critical care medicine.
CHEST® Pulmonary, a new open access journal, will advance the care of patients served by multidisciplinary clinicians across pulmonary and sleep medicine.
Advertisement
What did you find most interesting this month? Send us a message @journal_CHEST.
Watch the latest CHEST journal webinar.
Journal CHEST® authors, Daniel Lachant, DO, and R. James White, MD, PhD, discuss the article, "Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension."
Moderator: Nicholas A. Kolaitis, MD, MAS
General Information
Editor in Chief: Peter J. Mazzone, MD, MPH, FCCP
Published monthly Archived back to 1935
Submission/Review Stats
Acceptance rate: 8-10% for Original Research
Time to first decision: 3 weeks
Acceptance to publication: 2 to 3 weeks to Online First, 5 months to print
READY TO SUBMIT TO CHEST JOURNAL? Learn how to submit original research for consideration.
Impact Factor
Impact Factor Rank
Immediacy Index
Eigenfactor Score
Article Influence Score
VIEW MORE CITATION DATA »
When you become a member of CHEST, you’ll be automatically subscribed to the journal CHEST and receive alerts on the latest research as well as discounts on all that we offer.
GET THE LATEST RESEARCH UPDATES